Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

By
Andrea Surnit
March 31, 2026
3 min

Conexiant

Overview

Patients with postzoster neuralgia have a significantly elevated risk of developing tinnitus compared to matched controls. The study found a 1.35 times greater likelihood of tinnitus in this population, with risk varying by age and comorbid conditions.

Background

Incorporate specific statistics from the study to emphasize the importance of monitoring.

Data Highlights

Adjust the table for clarity and completeness, ensuring all relevant data is included.

Key Findings

Patients with postzoster neuralgia had a 1.35 times higher likelihood of developing tinnitus compared to matched controls.
The incidence of tinnitus was 146 cases per 10,000 person-years in the postzoster neuralgia group.
Patients aged 40-59 years had a 1.99 times higher risk of tinnitus, while those aged 60 years or older had a 2.37 times higher risk.
Comorbid conditions such as hearing loss, sleep disorders, and anxiety were associated with increased tinnitus risk.
Male patients exhibited a lower risk of tinnitus compared to female patients.

Clinical Implications

Healthcare providers should be vigilant in monitoring patients with postzoster neuralgia for signs of tinnitus, particularly in older patients and those with comorbid conditions. Early identification and management of tinnitus may improve patient outcomes and quality of life.

Conclusion

The findings underscore the importance of recognizing the heightened risk of tinnitus in patients with postzoster neuralgia, necessitating proactive management strategies to address this potential complication.